Skip to content
Isansys named as finalist in “Best Emerging Medtech” category at OBN 2011 Annual Awards

News -

Isansys named as finalist in “Best Emerging Medtech” category at OBN 2011 Annual Awards

Isansys Lifecare has been selected as a finalist for the OBN 2011 Annual Awards in the category of “Best Emerging Medtech”. The awards celebrate the key achievements within the bioscience sector over the last year. OBN is a not-for-profit business network which provides comprehensive support for biotech and medtech companies in the Oxford and South-East England biocluster and beyond.

The winners will be announced on 13th September 2011 at a gala dinner to be held at Pembroke College Oxford. The event will be attended by senior executives and influential players from the most innovative and dynamic biotech and medtech companies in the OBN network.

For more information and the full list of shortlisted companies, please visit: http://www.obn.org.uk/obn_/eventdetails.php?r=OQR8EU529471

Topics

Categories

Contacts

Georgina Horton

Georgina Horton

Press contact Head of Communications 01235 436225

Providing extraordinary new digital medical tools to transform patient data into valuable clinical insight

Isansys provides remote monitoring solutions which improve patient care, drive clinical performance, ensure economic value and enhance patient safety.

Headquartered in Oxfordshire, with subsidiaries in Germany, India and the US, Isansys is a privately limited company which was founded in 2010 by Keith Errey and Rebecca Weir.

Our business is to work with health professionals, insurance companies and healthcare organisations to provide more efficient patient monitoring against a backdrop of staff shortages and a rising number of patients and costs and limited budgets.

All our products and devices are fully certified and qualified medical devices.

Isansys
8C Park Square
OX14 4RR Oxford
United Kingdom